Impact of comorbidities on the mortality benefits of lung cancer screening: a post-hoc analysis of PLCO and NLST trials.
Gendarme S, Irajizad E, Long JP, Fahrmann JF, Dennison JB, Ghasemi SM, Dou R, Volk RJ, Meza R, Toumazis I, Canoui-Poitrine F, Hanash SM, Ostrin EJ.
Gendarme S, et al. Among authors: ghasemi sm.
J Thorac Oncol. 2025 Jan 9:S1556-0864(25)00004-8. doi: 10.1016/j.jtho.2025.01.003. Online ahead of print.
J Thorac Oncol. 2025.
PMID: 39798695